Study of the Kinesin Oral Molecular Degrader BBI-940 in Subjects With Advanced or Metastatic Breast Cancer
Clinical trial NCT07408089 · TERMINATED
Trial details
- NCT number
- NCT07408089
- Sponsor
- Boundless Bio, Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-02-25
- Primary completion
- 2026-07-28
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.